Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preliminary Data on the Nanopowder Hemostatic Agent TC-325 to Control Gastrointestinal Bleeding.

Literature DB >> 22299002

Preliminary Data on the Nanopowder Hemostatic Agent TC-325 to Control Gastrointestinal Bleeding.

Samuel A Giday¹.

Abstract

Entities: Chemical

Year: 2011 PMID： 22299002 PMCID： PMC3264976

Source DB: PubMed Journal: Gastroenterol Hepatol (N Y) ISSN： 1554-7914

× No keyword cloud information.

3 in total

1. ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage.

Authors: Douglas G Adler; Jonathan A Leighton; Raquel E Davila; William K Hirota; Brian C Jacobson; Waqar A Qureshi; Waqar A Quereshi; Elizabeth Rajan; Marc J Zuckerman; Robert D Fanelli; R David Hambrick; Todd Baron; Douglas O Faigel
Journal: Gastrointest Endosc Date: 2004-10 Impact factor: 9.427

2. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding.

Authors: J J Y Sung; D Luo; J C Y Wu; J Y L Ching; F K L Chan; J Y W Lau; S Mack; R Ducharme; P Okolo; M Canto; A Kalloo; S A Giday
Journal: Endoscopy Date: 2011-03-31 Impact factor: 10.093

3. Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.

Authors: S A Giday; Y Kim; D M Krishnamurty; R Ducharme; D B Liang; E J Shin; X Dray; D Hutcheon; K Moskowitz; G Donatelli; D Rueben; M I Canto; P I Okolo; A N Kalloo
Journal: Endoscopy Date: 2011-03-07 Impact factor: 10.093

3 in total

7 in total

1. Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors: Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal: World J Hepatol Date: 2016-02-08

Preliminary Data on the Nanopowder Hemostatic Agent TC-325 to Control Gastrointestinal Bleeding.

1. ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage.

2. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding.

3. Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model.

1. Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

2. Safety and efficacy of Hemospray® in upper gastrointestinal bleeding.

Review 3. Endoscopy for nonvariceal upper gastrointestinal bleeding.

4. Hemospray for Life-Threatening Ulcer Bleeding: First Case Report in the United States.

Review 5. Recent advances on the management of patients with non-variceal upper gastrointestinal bleeding.

6. Hemospray for recurrent esophageal band ulcer bleeding.

Review 7. State-of-the-art management of acute bleeding peptic ulcer disease.